Our Sustainability key indicators
| Strategic Goal | Value chain | Sustainability key indicator | 2025 | 2024 | More information | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Own operations | Percentage of newly published patent families with positive sustainability impact | 50 | 34 | – | |||||
| 1 | Downstream | Number of people treated with our Healthcare products (in million) | 182 | 184 | S4 | |||||
| 1 | Downstream | Number of people treated with pharmaceutical products enabled by our Life Science business sector (in million) | 408 | 402 | – | |||||
| 1 | Own operations | Reduction of number of animals used (in %)1 | 25 | 28 | G1 | |||||
| 2 | Own operations | Environment, health and safety (EHS) incident rate | 1.85 | 2.23 | S1 | |||||
| 2 | Own operations | Lost time injury rate (LTIR) | 0.98 | 1.16 | S1 | |||||
| 2 | Own operations | Injury Count Rate (ICR)1 | 2.15 | – | S1 | |||||
| 2 | Upstream | Percentage of relevant suppliers (in terms of number) that are covered by a valid sustainability assessment | 73 | 75 | S2 | |||||
| 2 | Upstream | Percentage of relevant suppliers (in terms of spend) that are covered by a valid sustainability assessment | 96 | 94 | S2 | |||||
| 2 | Upstream | Share of procurement spend attributable to suppliers with a valid sustainability assessment of "good" or higher (in %)1 | 59 | – | S2 | |||||
| 2 | Own operations | Violations of Global Social and Labor Standards Policy | 60 | 57 | S1 | |||||
| 3 | Own operations | Greenhouse gas emissions Scope 1 and 2 (in metric tons) | 854,908 | 1,085,124 | E1 | |||||
| 3 | Upstream; downstream | Indirect greenhouse gas emissions (Scope 3 intensity: metric tons CO2eq per € million gross profit) | 316 | 359 | E1 | |||||
| 3 | Upstream | Percentage of purchased electricity from renewable sources | 63.9 | 52.2 | E1 | |||||
| 3 | Own operations | Circularity rate (in %) | 70.1 | 69.2 | E5 | |||||
| 3 | Own operations | Water efficiency (m3 per € million net sales) | 539 | 588 | E3 |
